Xilinx Inc.

Xilinx designs and develops programmable devices and associated technologies, including: integrated circuits (ICs) in the form of programmable logic devices (PLDs), including programmable System on Chips and three-dimensional ICs; Adaptive Compute Acceleration Platform, a multi-core heterogeneous compute platform; software design tools to program the PLDs; software development environments and embedded platforms; targeted reference designs; printed circuit boards; and intellectual property (IP), which consists of the company and third-party verification and IP cores. In addition to its programmable platforms, the company provides design services, customer training, field engineering and technical support.
  • TickerXLNX
  • ISINUS9839191015
  • ExchangeNASDAQ Stock Market
  • SectorTechnology Hardware & Equipment
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: A number of Healthcare names are staging bullish reversals. (ex. CSTL, MDXG, STXS, PAVM, BLFS, HSKA, TMO, CRNX, and BLI) Several Technology companies are developing reversals or breaking to new highs. (ex. ARLO, TA, ENPH, AMD, XLNX, NVDA, ME, RVLV, SHOP, NET, VRNS, APPN, ASAN, SMAR, BILL, BLI, BLI, MDB, ZDGE, AZRE, and RUN.

Xilinx, Inc. - April 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

XILINX sees an upgrade to Slightly Negative thanks to a better star rating, but the title remains unattractive

The independent financial analyst theScreener just awarded an improved star rating to XILINX (US), active in the Semiconductors industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 2 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date May 28, 2021, the closing price was USD 127.00 and its target price was estimated at USD 99.92.

Xilinx, Inc. - January 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Xilinx, Inc. - January 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: A number of Healthcare names are staging bullish reversals. (ex. CSTL, MDXG, STXS, PAVM, BLFS, HSKA, TMO, CRNX, and BLI) Several Technology companies are developing reversals or breaking to new highs. (ex. ARLO, TA, ENPH, AMD, XLNX, NVDA, ME, RVLV, SHOP, NET, VRNS, APPN, ASAN, SMAR, BILL, BLI, BLI, MDB, ZDGE, AZRE, and RUN.

Valens Research

UAFRS vs As Reported Monthly Highlights - 2021 01 31

This month, Valens identified distortions and the corresponding adjustments to correct for those distortions for WIX, AMT, and XLNX.

MarketLine Department

Microsemi Corporation - Strategy, SWOT and Corporate Finance Report

Summary Microsemi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Microsemi Corporation (Microsemi or "the company"), a subsidiary of Microchip Technology Inc is a designer, manufacturer and marketer of semiconductor and system solutions.The company's major products include analog mixed-signal integrated circuits, field programmable gate arrays (FPGA...

MarketLine Department

NVIDIA Corporation - Strategy, SWOT and Corporate Finance Report

Summary NVIDIA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights NVIDIA Corporation (NVIDIA or the company) is a provider of visual computing solutions. The company designs graphics processing units (GPUs) and system on a chip units (SOCs) for gaming, professional visualization, datacenter and automotive markets. The company's GPU product brands includ...

MarketLine Department

Nvidia Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Nvidia Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Nvidia Corporation since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ...

Xilinx, Inc. - April 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Xilinx, Inc. - January 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Xilinx, Inc. - January 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Xilinx, Inc.: Update following placement of ratings under review for downgrade

Our credit view of Xilinx reflects its market leading position, modest leverage, excellent liquidity profile, constrained by its moderate scale and pending sale to AMD.

Xilinx, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

XILINX sees an upgrade to Slightly Negative thanks to a better star rating, but the title remains unattractive

The independent financial analyst theScreener just awarded an improved star rating to XILINX (US), active in the Semiconductors industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 2 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date May 28, 2021, the closing price was USD 127.00 and its target price was estimated at USD 99.92.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch